GE-exclusive ASiR and next generation technology to provide outstanding low-dose options for customers
CHICAGO--(BUSINESS WIRE)-- For decades GE Healthcare has invested in leading, state of the art technology for significantly lowering dose in computed tomography (CT) procedures. At the 96TH annual meeting of the Radiological Society of North America (RSNA) in Chicago, GE Healthcare is showcasing some of its latest CT innovations that provide dose-reducing options to customers to help ensure better diagnoses.
GE Healthcare’s exclusive ASiR (adaptive statistical iterative reconstruction) low dose reconstruction technology, available on the GE Discovery™ CT750 HD and LightSpeed VCT, can reduce dose by up to 40-50% while maintaining image quality and can be implemented as a cost-effective upgrade for existing GE LightSpeed VCT customers. The technology can be used on both helical and axial scans to reduce dose and maintain image quality for patients of all ages.
ASiR, in concert with GE’s SnapShot Pulse technology, further helps physicians to reduce dose cardiac imaging by more than 83%. ASiR is now routinely used with over 600 scanners worldwide, benefiting more than 15,000 patients per day on well over three million exams to date.
"I am astounded at how sharp the ASiR images are and how low the noise level is. This is very important, considering the significant dose savings that can be achieved with it,” noted Richard Kane MD, Director of Cardiovascular & Thoracic Radiology, Saint Francis Hospital, Evanston, IL.
GE’s Model-based Iterative Reconstruction Technology - Veo
GE is also highlighting the newest low-dose technology in the company’s CT portfolio–a model-based iterative reconstruction (MBIR) technology called Veo currently available in Europe. It is 510(k) pending at FDA and not yet available for sale in the U.S. When compared to previous GE reconstruction methods, Veo’s capabilities “change the rules” of CT imaging by applying revolutionary new modeling techniques to deliver lower noise, resolution gain, improved low contrast detectability and artifact suppression. Images—at unprecedented low dose levels—will be shown in the GE booth for various routine scan types.
“GE’s commitment offers tremendous promise for equipping radiologists and technologists with breakthrough technologies to reduce patient dose and improve image quality in their daily practice,” said Steve Gray, Vice President & General Manager of Computed Tomography & Advantage Workstation for GE Healthcare. “Through low-dose innovations, educational symposiums and collaborating directly with customers and the industry, we strive to help improve the overall care provided to patients.”
About GE Healthcare
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems.
Our “healthymagination” vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality around the world. Headquartered in the United Kingdom, GE Healthcare is a unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employees are committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com.
Arvind Gopalratnam, 262-501-0777
KEYWORDS: United States North America Illinois Wisconsin
INDUSTRY KEYWORDS: Health Hospitals Medical Devices Oncology Radiology Other Health General Health Managed Care